Just diagnosed with Idiopathic acute transverse myelitis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Idiopathic acute transverse myelitis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Idiopathic acute transverse myelitis hub →Overview
Idiopathic acute transverse myelitis is a rare condition. Tomeko brings together the specialists, research, clinical trials, treatments and community for Idiopathic acute transverse myelitis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:139423 · ICD-10 G37.3 · GARD 0019914
Find care for Idiopathic acute transverse myelitis
Authoritative references for Idiopathic acute transverse myelitis
Research & market landscape for Idiopathic acute transverse myelitis
Following Idiopathic acute transverse myelitis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Idiopathic acute transverse myelitis — the real-world landscape behind the condition, in one place.
- Latest Idiopathic acute transverse myelitis research on PubMed ↗
- Recruiting Idiopathic acute transverse myelitis trials on ClinicalTrials.gov ↗
- Explore the Idiopathic acute transverse myelitis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Idiopathic acute transverse myelitis and every rare condition. See how Tomeko works with industry →
Common questions
What is Idiopathic acute transverse myelitis?
Idiopathic acute transverse myelitis is a rare condition. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Idiopathic acute transverse myelitis together in one place.
What are the symptoms of Idiopathic acute transverse myelitis?
Symptoms of Idiopathic acute transverse myelitis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Idiopathic acute transverse myelitis.
How is Idiopathic acute transverse myelitis treated?
Treatment for Idiopathic acute transverse myelitis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Idiopathic acute transverse myelitis, and review current options with them.
What causes Idiopathic acute transverse myelitis — is it genetic?
The cause and inheritance of Idiopathic acute transverse myelitis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Idiopathic acute transverse myelitis can explain what it means for you and your family.
I was just diagnosed with Idiopathic acute transverse myelitis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Idiopathic acute transverse myelitis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Idiopathic acute transverse myelitis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Idiopathic acute transverse myelitis, filtered to your area.
Are there clinical trials for Idiopathic acute transverse myelitis?
Tomeko shows live, recruiting studies for Idiopathic acute transverse myelitis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- Acetazolamide-responsive myotonia
- Acquired porencephaly
- Actin accumulation myopathy
- Action myoclonus-renal failure syndrome
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute encephalopathy with biphasic seizures and late reduced diffusion